Anti-Androgen Receptor (phospho Y363)抗体(ab92563)


  • 产品名称Anti-Androgen Receptor (phospho Y363)抗体
    参阅全部 Androgen Receptor 一抗
  • 描述
    兔多克隆抗体to Androgen Receptor (phospho Y363)
  • 特异性ab92563 detects endogenous levels of Androgen Receptor only when phosphorylated at tyrosine 363.
  • 经测试应用适用于: WB, ELISA, IHC-Pmore details
  • 种属反应性
    与反应: Human
    预测可用于: Mouse, Rat
  • 免疫原

    Synthetic phosphopeptide derived from Human Androgen Receptor around the phosphorylation site of tyrosine 363 (DYYPNF).

  • 阳性对照
    • Extracts from Jurkat cells (treated with UV for 15 mins) IHC-P: Human prostate FFPE tissue sections.



Our Abpromise guarantee covers the use of ab92563 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
  • 应用说明ELISA: 1/10000.
    WB: 1/500 - 1/1000. Predicted molecular weight: 99 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.
      Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.
    • 组织特异性Isoform 2 is mainly expressed in heart and skeletal muscle (PubMed:15634333). Isoform 3 is expressed by basal and stromal cells of prostate (at protein level) (PubMed:19244107).
    • 疾病相关Androgen insensitivity syndrome
      Spinal and bulbar muscular atrophy X-linked 1
      Defects in AR may play a role in metastatic prostate cancer. The mutated receptor stimulates prostate growth and metastases development despite of androgen ablation. This treatment can reduce primary and metastatic lesions probably by inducing apoptosis of tumor cells when they express the wild-type receptor.
      Androgen insensitivity, partial
    • 序列相似性Belongs to the nuclear hormone receptor family. NR3 subfamily.
      Contains 1 nuclear receptor DNA-binding domain.
    • 结构域Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. In the presence of bound steroid the ligand-binding domain interacts with the N-terminal modulating domain, and thereby activates AR transcription factor activity. Agonist binding is required for dimerization and binding to target DNA. The transcription factor activity of the complex formed by ligand-activated AR and DNA is modulated by interactions with coactivator and corepressor proteins. Interaction with RANBP9 is mediated by both the N-terminal domain and the DNA-binding domain. Interaction with EFCAB6/DJBP is mediated by the DNA-binding domain.
    • 翻译后修饰Sumoylated on Lys-388 (major) and Lys-521. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity.
      Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-535 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-83 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition.
      Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.
    • 细胞定位Nucleus. Cytoplasm. Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of RACK1.
    • Information by UniProt
    • 数据库链接
    • 形式There are 2 isoforms produced by alternative splicing. Isoform 1 is also known as: AR-B; isoform 2 is known as AR-A or variant AR45.
    • 别名
      • AIS antibody
      • ANDR_HUMAN antibody
      • Androgen nuclear receptor variant 2 antibody
      • Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) antibody
      • Androgen receptor antibody
      • androgen receptor splice variant 4b antibody
      • AR antibody
      • AR8 antibody
      • DHTR antibody
      • Dihydro testosterone receptor antibody
      • Dihydrotestosterone receptor (DHTR) antibody
      • Dihydrotestosterone receptor antibody
      • HUMARA antibody
      • HYSP1 antibody
      • KD antibody
      • Kennedy disease (KD) antibody
      • NR3C4 antibody
      • Nuclear receptor subfamily 3 group C member 4 (NR3C4) antibody
      • Nuclear receptor subfamily 3 group C member 4 antibody
      • SBMA antibody
      • SMAX1 antibody
      • Spinal and bulbar muscular atrophy (SBMA) antibody
      • Spinal and bulbar muscular atrophy antibody
      • Testicular Feminization (TFM) antibody
      • TFM antibody
      see all

    Anti-Androgen Receptor (phospho Y363) antibody 图像

    • IHC image of Androgen Receptor (phospho Y363) staining in human prostate formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab92563, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

      For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

    • All lanes : Anti-Androgen Receptor (phospho Y363) antibody (ab92563) at 1/500 dilution

      Lane 1 : extracts from Jurkat cells, treated with UV (15mins)
      Lane 2 : extracts from Jurkat cells, treated with UV (15mins) with immunising peptide at 10 µg

      Lysates/proteins at 30 µg per lane.

      Predicted band size : 99 kDa

    Anti-Androgen Receptor (phospho Y363) antibody (ab92563)参考文献

    ab92563 has not yet been referenced specifically in any publications.

    Product Wall

    Thank you for confirming these details and for your cooperation. The details provided enable us to closely monitor the quality of our products. I am sorry this product did not perform as stated on the datasheet and for the inconvenience this has cau...

    Read More